ORAGENICS, INC. Inventory Write-down
ORAGENICS, INC. (OGEN) reported Inventory Write-down of -$240.00 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-10-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2013-10-25
- ORAGENICS, INC. inventory write-down for the quarter ending 2013-09-30 was $0.00.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month |
|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | -$240.00K 10-Q · filed 2013-10-25 | |
| 2013-06-30 | -$240.00K 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |